Castor RWE Platform Released to Facilitate Post-Marketing Clinical Trials

The clinical trial company Castor has announced the launch of its Castor RWE platform. The software extends the company’s real-world evidence (RWE) and real-world data (RWD) offerings. Using the platform, researchers can cut costs in post-marketing clinical trials and speed therapeutic deployment

According to Business Wire, “Castor RWE addresses common post-marketing clinical trial (PMCT) challenges by easily integrating real-world data sources such as patient-reported outcomes and wearables to increase patient access and retention as well as data quality and compliance. The offering, Castor Real-World Evidence (RWE), provides integrated technology and services to accelerate the collection of RWD for PMCT, enabling life science companies to meet regulatory and payer requirements efficiently.”

To read more, click here.

(Source: Business Wire, November 10^th, 2022)